PCB Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
WG
FWIA
PCB Capital's PFE Position: Q2 2026 in Review
PCB Capital increased its Pfizer (PFE) stake by 5.5% in Q2 2026, buying an estimated $57.2K and bringing the position to 41,946 shares worth $1.01M. The position accounts for 1.23% of the portfolio, ranked #28.
PCB Capital first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.12M in Q1 2026. 850 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- PCB Capital held 41,946 shares of Pfizer worth $1.01M as of Q2 2026.
- PCB Capital bought 2,188 Pfizer shares in Q2 2026, an estimated $57.2K.
- Pfizer made up 1.23% of PCB Capital's portfolio in Q2 2026, its #28 holding.
- PCB Capital first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
- PCB Capital's Pfizer position peaked at $1.12M in Q1 2026.
- 850 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on PCB Capital's 13F filing for Q2 2026, filed 20 Jul 2026.